KLF2 and triple-A syndrome: Since KLF2 is a flow-dependent key regulator with potent anti-inflammatory and anti-thrombotic effects, suppressing monocyte attachment and thrombus formation [37], this finding suggests an importance of endothelial shear stress as a novel therapeutic target of AAA.